Dec 13, 2024

Sequent Scientific Limited on the proposed acquisition of Viyash Life Sciences Private Limited and its subsidiaries.

AZB & Partners advised Sequent Scientific Limited on the proposed acquisition of Viyash Life Sciences Private Limited and its subsidiaries by way of an approx. INR 8,000 crore merger.

Our deal team comprised our Senior Partners Ashwath Rau and Kashish Bhatia, Counsel Himanshoo Tembe, Senior Associates A. Robin Singh and Dishti Kaji, Associates Yashi Saraswat and Meghna Somani.

 

AUTHORS & CONTRIBUTORS

TAGS

SHARE

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.